Filing Details
- Accession Number:
- 0001209191-12-043747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-30 15:01:01
- Reporting Period:
- 2012-08-29
- Filing Date:
- 2012-08-30
- Accepted Time:
- 2012-08-30 15:01:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145404 | Cornerstone Therapeutics Inc | CRTX | Pharmaceutical Preparations (2834) | 043523569 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1452285 | B Joshua Franklin | C/O Cornerstone Therapeutics Inc. 1255 Crescent Green Drive, Suite 250 Cary NC 27518 | Vp, Strategy & Bus. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-29 | 38,637 | $3.90 | 59,581 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-29 | 38,637 | $6.86 | 20,944 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock (Right to Buy) | Disposition | 2012-08-29 | 38,637 | $0.00 | 38,637 | $3.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-07-28 | 2018-10-31 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.85 to $6.93, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- Vesting of this option was accelerated, in connection with the closing of the transactions contemplated by the Stock Purchase Agreement, by and among Chiesi Farmaceutici SpA, ("Chiesi") and Cornerstone BioPharma Holdings, Ltd., and other related agreements entered into on May 6, 2009.
Billionaire Hedge Funds
